275 related articles for article (PubMed ID: 37582401)
21. Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication.
Nishida N; Kudo M
Oncology; 2017; 92 Suppl 1():40-49. PubMed ID: 27764823
[TBL] [Abstract][Full Text] [Related]
22. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
[No Abstract] [Full Text] [Related]
23. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
24. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
Zhang M; Zhao H; Gao H
Viral Immunol; 2022 Apr; 35(3):212-222. PubMed ID: 35099297
[TBL] [Abstract][Full Text] [Related]
26. The mononuclear phagocyte system in hepatocellular carcinoma.
Qiao DR; Shan GY; Wang S; Cheng JY; Yan WQ; Li HJ
World J Gastroenterol; 2022 Dec; 28(45):6345-6355. PubMed ID: 36533105
[TBL] [Abstract][Full Text] [Related]
27. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?
Hammad LN; Abdelraouf SM; Hassanein FS; Mohamed WA; Schaalan MF
J Immunotoxicol; 2013; 10(4):380-6. PubMed ID: 23350952
[TBL] [Abstract][Full Text] [Related]
28. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion.
Yang J; Xing Z
Exp Biol Med (Maywood); 2021 Sep; 246(17):1928-1937. PubMed ID: 34053234
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of intratumour inflammatory cytokine mRNA levels of hepatocellular carcinoma patients and activation of two distinct pathways govern IL-8 induced epithelial-mesenchymal transition in human hepatic cancer cell lines.
Peng S; Chen Y; Gong Y; Li Z; Xie R; Lin Y; Zou B; Li J; Zeng L
Cytokine; 2019 Jul; 119():81-89. PubMed ID: 30903867
[TBL] [Abstract][Full Text] [Related]
30. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment.
Liu WT; Jing YY; Gao L; Li R; Yang X; Pan XR; Yang Y; Meng Y; Hou XJ; Zhao QD; Han ZP; Wei LX
Cell Death Differ; 2020 Jan; 27(1):85-101. PubMed ID: 31065105
[TBL] [Abstract][Full Text] [Related]
31. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.
Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243
[TBL] [Abstract][Full Text] [Related]
32. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
[TBL] [Abstract][Full Text] [Related]
33. Identification of interleukin-16 production on tumor aggravation in hepatocellular carcinoma by a proteomics approach.
Takeba Y; Ohta Y; Ootaki M; Kobayashi T; Kida K; Watanabe M; Koizumi S; Otsubo T; Iiri T; Matsumoto N
Tumour Biol; 2021; 43(1):309-325. PubMed ID: 34897107
[TBL] [Abstract][Full Text] [Related]
34. The role of cytokines in hepatocellular carcinoma.
Budhu A; Wang XW
J Leukoc Biol; 2006 Dec; 80(6):1197-213. PubMed ID: 16946019
[TBL] [Abstract][Full Text] [Related]
35. Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study.
Hayashi T; Yamashita T; Terashima T; Suda T; Okada H; Asahina Y; Hayashi T; Hara Y; Nio K; Sunagozaka H; Takatori H; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
BMC Cancer; 2017 Dec; 17(1):870. PubMed ID: 29258450
[TBL] [Abstract][Full Text] [Related]
36. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
[TBL] [Abstract][Full Text] [Related]
37. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
[TBL] [Abstract][Full Text] [Related]
38. Single-cell analysis reveals HBV-specific PD-1
Liu L; Liu J; Li P; Luo J; Qin R; Peng Q; Li B; Wei X; Wang T; Shi H; Wang MD; Li C; Fang W; Chen W; Xu X; Yang T; Yin W; Zeng X
J Exp Clin Cancer Res; 2023 Jun; 42(1):152. PubMed ID: 37353792
[TBL] [Abstract][Full Text] [Related]
39. Role of m6A RNA methylation in the development of hepatitis B virus-associated hepatocellular carcinoma.
Zhang C; Dai D; Zhang W; Yang W; Guo Y; Wei Q
J Gastroenterol Hepatol; 2022 Nov; 37(11):2039-2050. PubMed ID: 36066844
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation.
Radaeva S; Sun R; Pan HN; Hong F; Gao B
Hepatology; 2004 May; 39(5):1332-42. PubMed ID: 15122762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
